Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amadeo B Biter

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Gynecologic Oncology|April 11, 2022
Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysisJi Son, Goldy C George, Mirella Nardo, et al.
Journal of Pharmaceutical Sciences|February 20, 2020
Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine CandidateWen-Hsiang Chen, Mun Peak Nyon, Mohan V Poongavanam, et al.
Protein Expression and Purification|September 13, 2020
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasisZhuyun Liu, Rakhi Kundu, Surafel Damena, et al.
Frontiers in Immunology|November 28, 2022
Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical dataJi Son, Rodney Cheng-En Hsieh, Heather Y Lin, et al.
Journal of Pharmaceutical Sciences|December 25, 2017
Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas DiseaseAmadeo B Biter, Sarah Weltje, Elissa M Hudspeth, et al.
JCO Precision Oncology|July 21, 2022
Identification of <i>KRAS</i><sup></sup> Mutations in Circulating Tumor DNA in Patients With CancerKyaw Z Thein, Amadeo B Biter, Kimberly C Banks, et al.
Journal of Pharmaceutical Sciences|May 1, 2017
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine CandidateWen-Hsiang Chen, Shivali M Chag, Mohan V Poongavanam, et al.
Journal of Immunotherapy and Precision Oncology|February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I TrialMirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Journal of Immunotherapy and Precision Oncology|February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical CancerJi Son, Heather Y Lin, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic CancersJi Son, Yingao Zhang, Heather Lin, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Gynecologic Oncology|April 11, 2022
Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysisJi Son, Goldy C George, Mirella Nardo, et al.
Journal of Pharmaceutical Sciences|February 20, 2020
Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine CandidateWen-Hsiang Chen, Mun Peak Nyon, Mohan V Poongavanam, et al.
Protein Expression and Purification|September 13, 2020
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasisZhuyun Liu, Rakhi Kundu, Surafel Damena, et al.
Frontiers in Immunology|November 28, 2022
Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical dataJi Son, Rodney Cheng-En Hsieh, Heather Y Lin, et al.
Journal of Pharmaceutical Sciences|December 25, 2017
Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas DiseaseAmadeo B Biter, Sarah Weltje, Elissa M Hudspeth, et al.
JCO Precision Oncology|July 21, 2022
Identification of <i>KRAS</i><sup></sup> Mutations in Circulating Tumor DNA in Patients With CancerKyaw Z Thein, Amadeo B Biter, Kimberly C Banks, et al.
Journal of Pharmaceutical Sciences|May 1, 2017
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine CandidateWen-Hsiang Chen, Shivali M Chag, Mohan V Poongavanam, et al.
Journal of Immunotherapy and Precision Oncology|February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I TrialMirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Journal of Immunotherapy and Precision Oncology|February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical CancerJi Son, Heather Y Lin, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic CancersJi Son, Yingao Zhang, Heather Lin, et al.
Pageof 2